Healthcare and Life Sciences investing.Kennedy Lewis’ private funds pursue a flexible all-weather investment strategy. Kennedy Lewis targets event-driven and opportunistic financings across public and private markets, and chiefly focuses on performing and growth investment opportunities in the US and Europe. The Firm’s strategy regularly focuses on middle-market companies facing disruption, whether it be cyclical, secular, or regulatory related. Kennedy Lewis also partners with high growth companies that are themselves causing disruption, providing structured capital solutions to fit their needs.Kennedy Lewis is committed to serving as a partner to borrowers, structuring loans that set a company up to succeed and creatively tailoring each investment to suit the needs of the company in a fiscally prudent manner. Through a rigorous and deep fundamental credit approach, complemented by established sector views, Kennedy Lewis’ portfolio construction concentrates on investments in sectors where capital can be deployed tactically to provide capital structure stability or, at times, fund growth.

Executive Advisor to Oxford Science Enterprises.Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via our unique partnership with the University of Oxford, the world’s #1 research university. This partnership enables us to work with the brightest academic minds tackling the world’s toughest challenges and guarantees us unrivalled access to their scientific research. In collaboration with our global network of entrepreneurs and advisors, we go well beyond funding to shape and nurture these complex ideas into successful businesses. Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, Deep Tech – we adopt a flexible, long-term investment approach, recognising the path from ground-breaking research to global markets takes time and resilience.To date, we have invested £0.6 billion in over 80 ambitious companies built on Oxford science, helping progress >50 from seed to Series A, and >20 to Series B and beyond, including 2 IPOs and 7 trade sales. A key player in Oxford’s entrepreneurial ecosystem, we are highly motivated to foster an environment that catalyses pioneering research and steers it to commercial success. We are committed to doing this in an inclusive and sustainable way.

Redesign Health is a company that powers innovation in healthcare by developing technologies, tools, and insights that lower the barriers to change across the industry. Since 2018, exceptional founders have built over 5 dozen companies at Redesign Health, impacting more than fifteen million lives across many aspects of the healthcare ecosystem including cancer care, teleaudiology, Perioperative Care, metabolic health, Cardiology management solutions and more.As a Venture Chair, my role is to facilitate the launch of our new Operating Companies, recruit outstanding management teams and facilitate growth of the companies by coordinating our network of Redesign internal experts with external advisors and oversee success of the companies from a board role, acting as chairman and a strategic advisor across the founding teams.

Business Leader, Global Head of Diagnostic Clinical Services and New VenturesActs as the business leader over the Global Diagnostic Clinical Services organization for Philips. Managed large physician group practice and back office support staff. Holds responsibility for leading Philips Radiology Managed Services practice at the global level which includes P&L management, growth and directional strategy, Mergers and Acquisitions, new venture creation, global alliances, and strategic partnerships. Leads strategy and M&A, including integration and execution, service design, and operational optimization for entering into this new business segment. Additionally, acts as a core member of the Global Leadership Team, developing a long-term growth strategy that is working to uncover and determine new business lines to invest in and enter.Notable Contributions: • Successfully managed and led multiple acquisitions for the company which has achieved 100% revenue increase and equal growth in relative value. • Commercialized new software technologies, introduced products to international markets, and developed integrated value propositions across multiple businesses within the organization which has led to 40% year over year sales growth.• Created and implemented a strategy to enter into Clinical Services which was a significant shift from the 100 year+ core business of Philips.

Member of WIllamette View Foundation board of directors and investment committee. The foundation serves residence of the large senior living communities philanthropic arm which provided financial support to residents who outlive their resources. Also provided investment direction and trust services for residents.

Successfully drove operational efficiency, sales growth, strategic partnerships, fundraising, rapid team building and new product development for this medical image analytics and deep learning company. Designed and developed image analysis algorithms that integrated with medical products. Led teams to enable the development and deployment of custom deep learning algorithms based on data by using intuitive tools in a secure HIPAA-compliant portal. Notable Contributions: • Provided custom solutions for medical imaging companies and researchers that wanted to enable their applications or devices with intelligence.• Increased sales by building strong relationships with clients and providing information about the cutting-edge technology offered by the company.• Forged strategic partnerships in order to develop this innovative medical technology.

Served as an active advocate and ambassador for the organization. Fully engaged in identifying and securing the financial resources and partnerships necessary for the organization to advance its mission. Leveraged connections, networks, and resources to develop collective action in order to fully achieve the organization’s mission.

Served on the board of directors for a Public Shell Vehicle, intended to roll-up molecular diagnostic technologies for public offering.

Founder and Managing DirectorOversaw and led fundraising, deal sourcing, due diligence and portfolio management of fund investments for this healthcare and life sciences-focused venture capital firm based in Portland, Oregon and Houston, Texas that founded in partnership with Oregon Health Sciences University and a grant from Nike Founder, Phil Knight. Focused on generating returns for investors through contributions of energy, expertise, and capital in emerging life sciences enterprises that are positioned to facilitate the evolution of the healthcare system. Developed and executed business strategies to achieve short and long-term goals. Reported to the board and provided market insights and strategic advice.Notable Contributions: • Worked collaboratively as part of the Allegory expansion and partnership with the Texas Medical Center which was the flagship fund within the Texas Medical Center Innovation Institute (TMCx).• Maintained positive and trust-based relationships with business partners, shareholders, and authorities.• Oversaw the company's business operations, financial performance, investments, and ventures.

At the request of the Texas Medical Center's CEO, was a founding strategic advisor during launch of TMCx and advised to all companies that were part of the TMCx accelerator programs. TMCx held multiple cohorts of companies each year ranging from Digital Health, Diagnostics, Therapeutics, Medical Devices and Services. Provided leadership advisory to founders, Hosted expert sessions for companies during the program, advised on go-to-market strategy, Legal, Finance, Fundraising, change management and leadership development. Acted as a panel speaker on multiple topics from venture investing, industry future state, healthcare trends and more.

Successfully led a middle-market investment bank and full-service financial services firm. Managed client assets and provided investment management and consulting to institutions as well as very high net worth clients and families. Possessed a strong focus on private and venture capital investments in healthcare technologies and technology-enabled business services.Notable Contributions: • Provided extensive investment management by ensuring due diligence, rigorous financial modeling, investment policy statement creation.

Discretionary portfolio management of the firm's investment clients.Drove risk-adjusted returns for the achievement of the client's targeted investment strategy.Developed investment policy statement, individualized for each client and managed portfolio to meet the conditions of IPS.